Google DeepMind, Meta, Isomorphic Labs Invest $300 Million in Biohub's Initiative to Build AI Data to Treat Disease
MT newswire2026/10/07 14:2010:20 AM EDT, 10/07/2026 (MT Newswires) -- Alphabet's (GOOGL, GOOG) Google DeepMind, Meta (META), and Isomorphic Labs are collectively investing $300 million in Biohub's Virtual Biology Initiative to build datasets for artificial intelligence models to predict and treat disease, Biohub said Wednesday. The investments will be used to create technologies and multi-modal datasets to enable the global scientific community to build and use AI models, allowing researchers to ask, predict, and answer biological questions digitally, Biohub said. Biohub added that the US Department of Energy will invest more than $500 million over five years in lab measurement, modeling and computation towards the initiative. Additionally, the US National Institutes of Health will coordinate the contribution of relevant datasets, repositories, and knowledge bases developed through over $500 million in prior similar federal initiatives, Biohub said. Price: 344.62, Change: -3.06, Percent Change: -0.88
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Moody’s gives Sky Protocol B3 rating as institutional interest in USDS grows
Brent crude oil falls to $104 per barrel, down 0.2% in 24 hours.
The relevant page of Hyperliquid Labs lists 5 OTC buyer wallet addresses.
BUZZ - Preview: Levi's shares decline, market focuses on high-end jeans sales
On Wednesday, October 7, Levi Strauss (LEVI.N) shares fell 4.3% to $19.65 ahead of the company's quarterly earnings release after the market close. With consumer spending becoming more cautious, investors are closely watching the company's progress in entering the premium jeans market. According to data from the London Stock Exchange Group (LSEG), the apparel manufacturer—known for its jeans and casual wear—is expected to report third-quarter revenue growth of about 5% year-on-year to $1.62 billion, with adjusted earnings per share at $0.36, higher than last year's $0.34. Last quarter, the company raised its annual sales forecast, betting that its premium jeans would attract high-income consumers, though its earnings outlook disappointed some investors. Jefferies, in a preview report, anticipated the third-quarter results would be "solid" given strong demand for jeans, and pointed out that the appointment of a new chief financial officer signals continued focus on future global growth. On September 30, Levi's announced the appointment of John Vandemore as chief financial officer, effective November 1, 2026; Vandemore previously worked at Skechers, where he served as corporate controller and led the global finance team for the past nine years. In response to this news, Levi's shares have declined about 5% year-to-date and approximately 20% over the past 12 months. Out of 16 brokerage firms, 13 rate the stock as "strong buy" or "buy," while 3 have it as "hold"; the median target price remains at $27, unchanged over the last three months.
Crypto prices
More
